InvestorsHub Logo
Followers 31
Posts 5802
Boards Moderated 0
Alias Born 04/20/2010

Re: hankmanhub post# 83656

Thursday, 11/17/2016 10:38:57 AM

Thursday, November 17, 2016 10:38:57 AM

Post# of 702661
Sure. Oh yeah, when is it starting?

From the university's PR:

After completing certain preparatory activities, including obtaining regulatory approvals, the Phase II trial will treat patients for up to 6 months with DCVax®-L and the checkpoint inhibitor Pembrolizumab, followed by long-term follow-up. The effects of this combination therapy will be monitored with magnetic resonance imaging (MRI) as well as “liquid biopsy” measures.



So what, another 6 months to start, 6 months to treat, and then long term follow up. Yay!

Given it takes the company 6 months to translate a contract....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News